STYXL1
Serine/threonine/tyrosine-interacting-like protein 1
Also known as: DUSP24, MK-STYX, STYL1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6J8
- Gene
- STYXL1
- Ensembl
- ENSG00000127952
- Chromosome
- 7
- Canonical length
- 313 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables protein phosphatase binding activity and pseudophosphatase activity. Involved in negative regulation of stress granule assembly; positive regulation of intrinsic apoptotic signaling pathway; and positive regulation of neuron projection development. Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
313 residues, UniProt reviewed canonical sequence.
>Q9Y6J8|STYXL1
1 MPGLLLCEPT ELYNILNQAT KLSRLTDPNY LCLLDVRSKW EYDESHVITA LRVKKKNNEY
61 LLPESVDLEC VKYCVVYDNN SSTLEILLKD DDDDSDSDGD GKDLVPQAAI EYGRILTRLT
121 HHPVYILKGG YERFSGTYHF LRTQKIIWMP QELDAFQPYP IEIVPGKVFV GNFSQACDPK
181 IQKDLKIKAH VNVSMDTGPF FAGDADKLLH IRIEDSPEAQ ILPFLRHMCH FIEIHHHLGS
241 VILIFSTQGI SRSCAAIIAY LMHSNEQTLQ RSWAYVKKCK NNMCPNRGLV SQLLEWEKTI
301 LGDSITNIMD PLYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STYXL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 43 nTPM
- fallopian tube: 27 nTPM
- pancreas: 21 nTPM
- testis: 21 nTPM
- tonsil: 20 nTPM
- epididymis: 20 nTPM
Single-cell type
- esophageal apical cells: 171 nCPM
- late primary spermatocytes: 116 nCPM
- respiratory ciliated cells: 93 nCPM
- fallopian tube ciliated cells: 87 nCPM
- early spermatids: 85 nCPM
- late spermatids: 82 nCPM
Immune cell
- basophil: 71 nTPM
- classical monocyte: 53 nTPM
- eosinophil: 50 nTPM
- NK-cell: 50 nTPM
- intermediate monocyte: 48 nTPM
- non-classical monocyte: 47 nTPM
Brain region
- choroid plexus: 24 nTPM
- white matter: 21 nTPM
- basal ganglia: 19 nTPM
- pons: 18 nTPM
- cerebral cortex: 18 nTPM
- amygdala: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.41
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.6
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular signal transduction
- negative regulation of stress granule assembly
- positive regulation of intrinsic apoptotic signaling pathway
- positive regulation of neuron projection development
- regulation of intrinsic apoptotic signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STYXL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STYXL1 as an antibody target. Whether an autoantibody or antibody against STYXL1 could matter depends on whether native STYXL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STYXL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STYXL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...